Citations

1. (1999). BCG immunotherapy of bladder cancer: 20 years on.
2. (2000). Cancer vaccines 1623
3. (1996). Comparison of IL-2 and IL-4 transfected B16-F10 cells with a novel oil-microemulsion adjuvant for B16-F10 whole cell tumour vaccine. Gene Therapy 3(10): 853–858 Souberbielle
4. (1996). Is cancer dangerous to the immune system? Semin Immunol 8(5): 271–280 Gilboa E
5. (1997). Role of Fas ligand (CD95L) in immune escape: the tumour cell strikes back.
6. (1989). Studies on the mechanism of action.
7. (1999). Tumour escape from the immune response: the last hurdle for successful immunotherapy of cancer? Cancer Immunol Immunother 48(7): 343–345

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.